3,4-dihydroxyphenylacetic acid has been researched along with 6-nitronorepinephrine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forsberg, M; Huotari, M; Kotisaari, S; Laitinen, K; Männistö, PT; Nordberg, HL; Passlin, M; Reenilä, I; Shintani, F; Tanaka, KF; Tuomisto, L | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 6-nitronorepinephrine
Article | Year |
---|---|
Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Binding, Competitive; Carrier Proteins; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Space; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Monoamine Oxidase; Neostriatum; Nerve Tissue Proteins; Neurons; Nitric Oxide; Nitrophenols; Norepinephrine; Piperazines; Rats; Rats, Wistar; Tolcapone | 2001 |